Tenax Therapeutics (NASDAQ:TENX) Coverage Initiated at StockNews.com
Analysts at StockNews.com began coverage on shares of Tenax Therapeutics (NASDAQ:TENX – Get Free Report) in a report issued on Friday. The firm set a “sell” rating on the specialty pharmaceutical company’s stock. TENX has been the subject of several other reports. Leerink Partners set a $20.00 price objective on Tenax Therapeutics in a research […]
Analysts at StockNews.com began coverage on shares of Tenax Therapeutics (NASDAQ:TENX – Get Free Report) in a report issued on Friday. The firm set a “sell” rating on the specialty pharmaceutical company’s stock. TENX has been the subject of several other reports. Leerink Partners set a $20.00 price objective on Tenax Therapeutics in a research […]
